Exane Derivatives Zoetis Inc. Transaction History

Exane Derivatives

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$155.97 - $200.09 $1.83 Million - $2.34 Million	-11,701 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$181.39 - $234.03 $2.12 Million - $2.74 Million	11,701 New	11,701 $2.21 Million
Q4 2021 Jan 28, 2022	SELL	$193.69 - $247.03 $2.17 Million - $2.77 Million	-11,202 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$189.29 - $209.69 $9,843 - $10,903	52 Added 0.47%	11,202 $2.17 Million
Q2 2021 Jul 28, 2021	SELL	$155.9 - $187.99 $648,076 - $781,474	-4,157 Reduced 27.16%	11,150 $2.08 Million
Q1 2021 Apr 30, 2021	SELL	$144.0 - $169.39 $645,984 - $759,883	-4,486 Reduced 22.66%	15,307 $2.41 Million
Q4 2020 Jan 27, 2021	SELL	$157.07 - $174.35 $603,934 - $670,375	-3,845 Reduced 16.27%	19,793 $3.28 Million
Q3 2020 Oct 08, 2020	BUY	$137.1 - $165.37 $3.24 Million - $3.91 Million	23,638 New	23,638 $3.91 Million
Q3 2020 Oct 06, 2020	SELL	$137.1 - $165.37 $3.13 Million - $3.77 Million	-22,796 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$111.92 - $142.53 $202,127 - $257,409	-1,806 Reduced 7.34%	22,796 $3.12 Million
Q1 2020 Apr 17, 2020	BUY	$92.66 - $144.94 $313,005 - $489,607	3,378 Added 15.92%	24,602 $2.9 Million
Q4 2019 Jan 22, 2020	BUY	$116.25 - $133.25 $718,308 - $823,351	6,179 Added 41.07%	21,224 $2.81 Million
Q3 2019 Oct 15, 2019	BUY	$112.57 - $128.43 $599,998 - $684,531	5,330 Added 54.86%	15,045 $1.87 Million
Q2 2019 Jul 12, 2019	BUY	$97.98 - $114.28 $54,770 - $63,882	559 Added 6.11%	9,715 $0
Q1 2019 Apr 24, 2019	BUY	$81.56 - $100.67 $746,763 - $921,734	9,156 New	9,156 $0

1,925

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $85.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.